Sweden · Health Care startup
Sweden · IRLAB Therapeutics
IRLAB Therapeutics is a drug discovery and development company providing novel treatments for disorders of the brain.
Funding reportedLast round: Grant
What company datasets say IRLAB Therapeutics raised
Funding, as reported
Reported in all17.9Min the source's currency
Rounds3
Last roundGrant
Last round dateDec 2023
Investors listed5
Founders and team
From IRLAB Therapeutics's own website: 5 on the team.
- Nicholas WatersExecutive Vice President and Head of R&D
- Kristina TorfgårdCEO
- Gustaf AlbèrtChief Financial Officer (CFO)
- Joakim TedroffChief Medical Officer (CMO)
- Susanna Holm WatersDirector of Systems Pharmacology
Health Care in Sweden
Startups like it
Is this your company?
Add your raise, your deck and your story, and put IRLAB Therapeutics in front of investors. Or tell us what we have wrong.